|
시장보고서
상품코드
1983137
슈도우리딘 시장 : 제품 유형별, 순도별, 형태별, 용도별, 최종사용자별, 팩 사이즈별, 유통 채널별, 지역별Pseudouridine Market, By Product Type , By Purity, By Form, By Application, By End User, By Pack Size, By Distribution Channel, By Geography |
||||||
슈도우리딘 시장은 2026년에 3,990만 달러로 추정되며, 2033년까지 5,470만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 4.6%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 3,990만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 4.60% | 2033년 시장 규모 예측: | 5,470만 달러 |
세계 슈도우리딘 시장은 RNA 변형 및 치료 응용 분야에서 동화합물의 중요한 역할에 힘입어 제약 및 생명공학 산업에서 빠르게 발전하고 있는 분야입니다. 종종 "제5의 뉴클레오시드"라고 불리는 슈도우리딘은 자연적으로 존재하는 변형된 뉴클레오시드이며, 세포 과정, 특히 리보솜 RNA와 전이 RNA의 안정성과 기능에서 필수적인 역할을 합니다. 이 우리딘의 이성질체는 mRNA 백신 기술에서 매우 중요한 역할을 하기 때문에 최근 큰 주목을 받고 있습니다. 특히 COVID-19 팬데믹 이후, 퓌소이드 우리진에 의한 변형이 고효능 mRNA 백신의 개발을 가능하게 했습니다.
백신에 적용하는 것 외에도, 슈도우리딘은 RNA의 안정성과 면역 회피가 매우 중요한 유전자 치료, 암 치료 및 다양한 치료 중재에서 유망한 가능성을 보여주고 있습니다. 이 시장에는 연구기관, 제약회사, 생명공학 기업에서 널리 사용되는 합성 슈도우리딘, 변형된 슈도우리딘 유도체, 슈도우리딘 함유 올리고뉴클레오티드 등 다양한 형태가 포함됩니다. RNA 생물학에 대한 이해도가 높아지고 혁신적인 치료법에 대한 수요가 증가함에 따라, 진행 중인 연구 이니셔티브, 규제 당국의 승인, 맞춤형 의료 및 첨단 치료 플랫폼에 대한 적용 확대에 힘입어 슈도우리딘 시장은 큰 폭의 성장이 예상됩니다.
시장 역학
세계 슈도우리딘 시장은 주로 mRNA 백신 기술의 전례 없는 성공과 광범위한 보급에 의해 주도되고 있습니다. 이 기술은 치료 효과와 안전성을 달성하는 데 있어서 슈도우리딘 변형이 얼마나 중요한지 입증했습니다. COVID-19 팬데믹은 mRNA 기반 치료제에 대한 막대한 투자를 촉진하고, 고품질 슈도우리딘 화합물에 대한 상당한 수요를 창출하여 시장 확장을 주도했습니다. 또한, 유전자 치료, 암 면역치료, RNA 기반 약물전달 시스템 분야의 연구 활동이 활발해지면서 시장 성장을 촉진하고 있습니다. 이는 슈도우리딘 변형이 RNA의 안정성을 높이고, 면역원성을 감소시키며, 치료 결과를 개선하기 때문입니다.
만성질환의 유병률 증가와 맞춤형 의료 접근에 대한 요구가 높아지면서 제약사들이 표적 치료를 위한 혁신적인 솔루션을 모색하고 있는 것도 시장 촉진요인으로 작용하고 있습니다. 그러나 시장은 전문 지식과 첨단 장비를 필요로 하는 복잡한 제조 공정과 같은 심각한 제약에 직면해 있으며, 이는 생산 비용의 상승과 공급업체 기반의 제한으로 이어지고 있습니다. RNA 기반 치료제를 둘러싼 규제적 복잡성과 제약 등급 슈도우리딘에 대한 엄격한 품질 요건은 시장 진입과 확장에 대한 또 다른 장벽이 되고 있습니다. 또한, 지적재산권 관련 이슈와 특허 상황으로 인해 일부 제조업체의 시장 접근이 제한될 수 있습니다.
이러한 제약에도 불구하고, 단백질 대체 요법, 조직공학, 재생의료와 같은 신흥 응용 분야에는 큰 기회가 존재하며, 이 분야에서는 슈도우리딘 변형 RNA가 우수한 치료 효과를 발휘할 수 있습니다. 다양한 치료 분야에 걸친 RNA 기반 치료제 파이프라인의 확대는 제조 기술의 발전과 연구 자금의 증가와 함께 분자 의학의 진화하는 트렌드를 활용하고자 하는 시장 진입 기업들에게 유망한 성장 기회를 제공하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 시장 규모와 예측 기간(2026-2033년)의 연평균 성장률(CAGR)을 제시하는 세계 슈도우리딘 시장에 대한 상세한 분석을 제공합니다.
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 보고서에서는 회사 개요, 제품 포트폴리오, 주요 특징, 재무 성과 및 전략과 같은 매개 변수를 기반으로 세계 슈도우리딘 시장의 주요 업체를 프로파일링합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 슈도우리딘 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 슈도우리딘 시장 : 제품 유형별(화학적 성질별), 2021-2033년
제5장 세계의 슈도우리딘 시장 : 순도별, 2021-2033년
제6장 세계의 슈도우리딘 시장 : 형태별, 2021-2033년
제7장 세계의 슈도우리딘 시장 : 용도별, 2021-2033년
제8장 세계의 슈도우리딘 시장 : 최종사용자별, 2021-2033년
제9장 세계의 슈도우리딘 시장 : 팩 사이즈별, 2021-2033년
제10장 세계의 슈도우리딘 시장 : 유통 채널별, 2021-2033년
제11장 세계의 슈도우리딘 시장 : 지역별, 2021-2033년
제12장 경쟁 구도
제13장 애널리스트의 추천
제14장 참고문헌 및 조사 방법
KSM 26.04.15Pseudouridine Market is estimated to be valued at USD 39.9 Mn in 2026 and is expected to reach USD 54.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 39.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.60% | 2033 Value Projection: | USD 54.7 Mn |
The global pseudouridine market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, driven by the compound's critical role in RNA modifications and therapeutic applications. Pseudouridine, often referred to as the fifth nucleoside, is a naturally occurring modified nucleoside that plays essential functions in cellular processes, particularly in ribosomal RNA and transfer RNA stability and function. This isomer of uridine has gained significant attention in recent years due to its pivotal role in mRNA vaccine technology, particularly following the COVID-19 pandemic, where pseudouridine modifications enabled the development of highly effective mRNA vaccines.
Beyond vaccine applications, pseudouridine demonstrates promising potential in gene therapy, cancer treatment, and various therapeutic interventions where RNA stability and immune evasion are crucial. The market encompasses various forms including synthetic pseudouridine, modified pseudouridine derivatives, and pseudouridine-containing oligonucleotides used across research institutions, pharmaceutical companies, and biotechnology firms. As the understanding of RNA biology advances and the demand for innovative therapeutic modalities increases, the pseudouridine market is positioned for substantial growth, supported by ongoing research initiatives, regulatory approvals, and expanding applications in personalized medicine and advanced therapeutic platforms.
Market Dynamics
The global pseudouridine market is primarily driven by the unprecedented success and widespread adoption of mRNA vaccine technology, which has demonstrated the critical importance of pseudouridine modifications in achieving therapeutic efficacy and safety. The COVID-19 pandemic catalyzed massive investments in mRNA-based therapeutics, creating substantial demand for high-quality pseudouridine compounds and driving market expansion. Additionally, growing research activities in gene therapy, cancer immunotherapy, and RNA-based drug delivery systems are fueling market growth, as pseudouridine modifications enhance RNA stability, reduce immunogenicity, and improve therapeutic outcomes.
The increasing prevalence of chronic diseases and the need for personalized medicine approaches further contribute to market drivers, as pharmaceutical companies seek innovative solutions for targeted therapies. However, the market faces significant restraints including complex manufacturing processes that require specialized expertise and sophisticated equipment, leading to high production costs and limited supplier base. Regulatory complexities surrounding RNA-based therapeutics and the stringent quality requirements for pharmaceutical-grade pseudouridine create additional barriers for market entry and expansion. Furthermore, intellectual property challenges and patent landscapes may restrict market accessibility for some manufacturers.
Despite these constraints, substantial opportunities exist in emerging applications such as protein replacement therapies, tissue engineering, and regenerative medicine, where pseudouridine-modified RNAs can provide superior therapeutic benefits. The expanding pipeline of RNA-based therapeutics across various therapeutic areas, coupled with advancing manufacturing technologies and increasing research funding, presents lucrative growth prospects for market participants seeking to capitalize on the evolving landscape of molecular medicine.
Key Features of the Study
- This report provides in-depth analysis of the global pseudouridine market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pseudouridine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include TriLink BioTechnologies, Yamasa Corporation Biochemicals Division, Hongene Biotech, Roche CustomBiotech, Thermo Fisher Scientific, Biosynth, Jena Bioscience, Yeasen Biotechnology, ULCHO Biochemical, Glycogene, Shanghai AECOM Biotechnology, Tianjin Scaxchem, Wuhu Huaren Science and Technology, Jinan Carbotang Biotech, and Hangzhou TCM Biotech
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pseudouridine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pseudouridine market
Market Segmentation
- Product Type (chemistry) Insights (Revenue, USD Mn, 2021 - 2033)
- Pseudouridine
- N1-methylpseudouridine
- Purity Insights (Revenue, USD Mn, 2021 - 2033)
- Research Grade (RUO)
- GMP / Clinical Grade
- Commercial / API Grade
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Powder (lyophilized / crystalline)
- Solution (aqueous / buffered)
- Application Insights (Revenue, USD Mn, 2021 - 2033)
- mRNA Therapeutics (human)
- mRNA Vaccines (human)
- mRNA Veterinary (vaccines / therapeutics)
- Oligonucleotide / RNA Tools (controls, standards, probes)
- Cell & Gene Therapy Research (RNA engineering workflows)
- Diagnostics & Assays (RNA-based kits, calibration materials)
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Pharma & Biopharma Companies
- CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish)
- CROs (preclinical/clinical support labs)
- Academic & Research Institutes
- Government / Public Health Labs
- Diagnostic Companies
- Pack Size Insights (Revenue, USD Mn, 2021 - 2033)
- Micro (<=100 mg)
- Small (100 mg-1 g)
- Medium (1-25 g)
- Bulk (25 g)
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- TriLink BioTechnologies
- Yamasa Corporation Biochemicals Division
- Hongene Biotech
- Roche CustomBiotech
- Thermo Fisher Scientific
- Biosynth
- Jena Bioscience
- Yeasen Biotechnology
- ULCHO Biochemical
- Glycogene
- Shanghai AECOM Biotechnology
- Tianjin Scaxchem
- Wuhu Huaren Science and Technology
- Jinan Carbotang Biotech
- Hangzhou TCM Biotech
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Pseudouridine Market, By Product Type (Chemistry)
- Global Pseudouridine Market, By Purity
- Global Pseudouridine Market, By Form
- Global Pseudouridine Market, By Application
- Global Pseudouridine Market, By End User
- Global Pseudouridine Market, By Pack Size
- Global Pseudouridine Market, By Distribution Channel
- Global Pseudouridine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Pseudouridine Market, By Product Type (Chemistry), 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pseudouridine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- N1-methylpseudouridine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Pseudouridine Market, By Purity, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Research Grade (RUO)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- GMP / Clinical Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Commercial / API Grade
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Pseudouridine Market, By Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Powder (lyophilized / crystalline)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Solution (aqueous / buffered)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Pseudouridine Market, By Application, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- mRNA Therapeutics (human)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- mRNA Vaccines (human)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- mRNA Veterinary (vaccines / therapeutics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Oligonucleotide / RNA Tools (controls, standards, probes)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cell & Gene Therapy Research (RNA engineering workflows)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostics & Assays (RNA-based kits, calibration materials)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Pseudouridine Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pharma & Biopharma Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CDMOs / CMOs (RNA synthesis, LNP formulation, fill-finish)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- CROs (preclinical/clinical support labs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Government / Public Health Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Diagnostic Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Pseudouridine Market, By Pack Size, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Micro (<=100 mg)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Small (100 mg-1 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Medium (1-25 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Bulk (25 g)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
10. Global Pseudouridine Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
11. Global Pseudouridine Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type (Chemistry), 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Purity, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Pack Size, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- TriLink BioTechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yamasa Corporation Biochemicals Division
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hongene Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche CustomBiotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biosynth
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jena Bioscience
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Yeasen Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ULCHO Biochemical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Glycogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Shanghai AECOM Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tianjin Scaxchem
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wuhu Huaren Science and Technology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jinan Carbotang Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hangzhou TCM Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
